Intervention and medicinal approaches to the management of patients with heart rhythm problems.International medical conference
Dates: May 16-17, 2018
Online registration is required.No admission without registration confirmation.
(deadline – March 20, 2018)
Sick Sinus Syndrome • Electrophysiological Substrate • Natural History • Update in Prognosis and Treatment Atrial Fibrillation • Epidemiology and Social Burden • Classification • Anatomical and Electrical Changes • Prognosis • Pharmacological and Non-Pharmacological Treatment • Non Antiarrhythmic Drugs to Prevent Atrial Fibrillation Recurrences • Cost-Benefit of The Various Therapeutical Strategies • Equal Access to Therapy for All The Patients • External, Esophageal, Internal Cardioversion • Permanent Anticoagulation New and Old Drugs • Percutaneous Closure of The Left Atrial Appendage • Post CABG Atrial Fibrillation Prevention and Treatment • Non-Antiarrhythmic Drugs for AF Prevention • Stroke Prevention by AF Early Detection • Transtelephonic Remote Control • Disease Management and Comorbidities AV and Intraventricular Conduction Disturbances • In The Acute Myocardial Infarction Setting • Progression and Prognosis • Hemodynamic Imbalance • Echocardiographic Evaluation • Appropriate Device Implantation and Programming • Temporary Pacing During Non Cardiac Surgery Sudden Death • Epidemiology and Classification • Underlying Heart Disease • Prevention • Identification of Candidates and of The Most Appropriate Treatment • Cost-Benefit • Equal Access to Therapy for All The Patients • Automatic External Defibrillation: Devices, Training Programs, Cost-Benefit Non Invasive Sudden Death Risk Stratification • QT Dynamicity • T Wave Alternans • Heart Rate Variability and Turbulence • Baroreflex Sensitivity • QRS Width Heart Failure • Atrial Fibrillation • Malignant Ventricular Tachyarrhythmias • Inter and Intraventricular Dissinchrony • AV Nodal Conduction Troubles • Supraventricular and Ventricular Repetitive Ectopic Beats • Echocardiographic Evaluation • Cardiac Revascolarization Benefits • Emerging Role of the Heart Failure/Device Specialists Genetic Arrhythmias • Brugada Syndrome • Arrhythmogenic Right Ventricular Dysplasia • Long QT Syndrome • Short QT Syndrome • Cathecolaminergic Ventricular Tachycardia Hypertrophic Cardiomiopathy • Identification of Candidates to Sudden Death • Various Therapeutical Strategies (Pacing, ICD, Alchoolization) Arrhythmias in Diabetic Patients Pediatric Arrhythmias • Clinical Issues • Electrophysiology and Pacing in Pediatric Patients Sleep Apnea Cardiac Syncope • Neuromediated-Orthostatic • In Patients with Structural Heart Disease • In Patients with Genetic Disease • Diagnostic Flow-Chart • Pharmacological Treatment • Indications to Permanent Pacing • Special Pacing Algorithms • Implantable Diagnostic Tools • Body Posture and Drugs Influence • Prognostic Signifi cance • Data from Registries and Trials Echocardiography in Arrhythmology • Identifi cation of Atrial Thrombo-Embolic Sources • Evaluation of Intraventricular and Interventricular Delay • Selection of Coronary Sinus Lead Appropriate Site in CRT • Optimal AV Interval Programming in DDD Pacing • Optimal VV Timing in CRT • Patient Risk Stratifi cation Post Myocardial Infarction • Indications to Lead Extraction • Intraprocedure Cardiac Tamponade • Intracardiac Echocardiography Arrhythmias in Athletes • Prognostic Signifi cance • Eligibility for Competitive Sports • Selection of the Most Appropriate Sport Activity • Diagnostic and Therapeutic Flow-Chart • Sport Practice in Pacemaker and ICD Patients
Call for Poster Abstracts:
Abstract submission deadline: April 20, 2018
Acceptance notification: April 22, 2018
The Scientific Program Committee invites you to submit your research in the form of a one-page abstract (2500 characters) . We welcome scholarly research-based submissions . Case study abstracts will also be welcomed.
Abstracts should include unpublished material and data. Material that has been formally published by the abstract submission dates will not be accepted. Most abstracts without data to support findings will be rejected. However, abstracts that describe study design and methods for well-developed and/or funded studies (i.e., no abstracts for pilot or preliminary studies) may be considered for poster presentation depending on abstract quality.
All abstracts will be anonymously peer reviewed, scored and chosen on merit for poster presentation.
Individuals whose abstract are selected will be required to register for the meeting; abstracts from authors who do not register will not be accepted.
Conditions of participation for participants:
Registration Package includes simultaneous translation from Russian to English language , certificate of participation (English language) ,participation in scientific sessions, conference materials, visit to the exhibition and 10-30% discount for accomodation in hotel.
(deadline – March 20, 2018)